Khoja

Khoja v. Orexigen Therapeutics, Inc.

Good Law
United States District Court, Southern District of CaliforniaNovember 2, 20203:15-cv-00540California10,186 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 10 KARIM KHOJA, on behalf of himself and Case No.: 15-CV-540 JLS (JLB) all others similarly situated,

ORDER (1) GRANTING IN PART

Plaintiff, AND DENYING IN PART MOVING v. DEFENDANTS’ REQUEST TO

CONSIDER MATERIALS

OREXIGEN THERAPEUTICS, INC.,

INCORPORATED BY REFERENCE,

JOSEPH P. HAGAN, MICHAEL A.

AND (2) GRANTING MOVING

NARACHI, and PRESTON KLASSEN,

DEFENDANTS’ PARTIAL MOTION

Defendants. TO DISMISS

18 AND ALL CONSOLIDATED CASES (ECF No. 114)

Presently before the Court is Moving Defendants Joseph P. Hagan, Michael A. Narachi, and Preston Klassen, M.D., M.H.S.’s Partial Motion to Dismiss Consolidated Amended Complaint for Violation of the Federal Securities Laws (“Mot.,” ECF No. 114),1 as well as Lead Plaintiff Karim Khoja’s Opposition to (“Opp’n,” ECF No. 115) and Moving Defendants’ Reply in Support of (“Reply,” ECF No. 116) the Motion.

26 1 Defendant…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.